Dr. Dangs Lab (DDL) was established in 1983, under the expert guidance of Dr. Navin Dang and Dr. Manju Dang, both MDs in Microbiology and Pathology from the nationally eminent PGIMER, Chandigarh. Their legacy is now carried forward by Dr. Arjun Dang (CEO) and Dr. Manavi Dang (Co-CEO), both consultant pathologists, continuing a physician-led model of scientific and operational leadership rooted in quintessential quality diagnostics.
Since its inception, DDL has functioned as a doctor-driven reference laboratory delivering premium, high-quality diagnostic services, with a sustained emphasis on accuracy, reliability, and clinical relevance. Over the years, our lab has progressively expanded its scope into clinical trials, evolving into a central reference laboratory supporting extensive collaborations with renowned pharmaceutical companies, CROs, academic institutions, and global sponsors. This has led to contributions in more than 70 clinical studies across vaccines and multiple therapeutic areas.
As an NABL-accredited lab since its early years, DDL was among the first laboratories in India to achieve this certification. Our central lab strictly adheres to ISO 15189:2022 and operates under GCLP guidelines, reinforcing our robust quality systems designed to support reliable, audit-ready, regulatory compliance.
Winner of Excellence in Contribution to Clinical Trials at 6th Edition of The Economic Times RE-Pharma Awards 2026.
Winner of the Inaugural BW Pharma World Pharma Leadership Award 2026 in the category of Excellence in Clinical Trials & Studies (Institutional Award).
The award was presented to Dr. Arjun Dang by Manoj Kumar Tiwari, recognizing excellence as a leading central laboratory for clinical trials and studies.
Winner of Excellence in Central Laboratory Services for Clinical Trials at the 4th Diagnostics Innovation & Excellence Awards 2026.
Awarded by the Quality Council of India (QCI) as the Best National Lab in its inception year.
Dr. Dangs Lab (DDL) brings over four decades of diagnostic expertise, grounded in a physician-led legacy and supported by experienced medical and scientific professionals. This foundation underpins our laboratory's evolution into a reliable central lab for clinical research.
For the past decade, Dr. Dangs Lab has functioned as a central lab supporting clinical trials, offering highly personalized central laboratory services aligned with study-specific requirements. Our central lab works closely with pharmaceutical companies, CROs, and academic institutions to support a broad range of clinical studies and research programs.
A defining strength of Dr. Dangs Central Lab lies in our ability to adapt our services to niche and esoteric study needs. To date, our central laboratory has supported more than 70 clinical trials across multiple indications, including infectious diseases, rare diseases, therapeutics, and vaccines.
Dr. Dangs Central Lab is committed to the use of gold-standard instrumentation and robust quality practices, maintaining high standards of analytical accuracy, safety, and reliability across all central lab services.
Dr. Dangs Lab actively collaborates with sponsors, CROs, research institutions, healthcare organizations, and pharmaceutical companies to foster meaningful scientific collaboration and knowledge exchange in clinical research.
These partnerships enable participation in a wide range of research initiatives and support the development and evaluation of new therapeutic and diagnostic approaches across multiple study phases and therapeutic areas.
Through close collaboration with our partners, we align laboratory strategy with study objectives, timelines, and quality expectations, enabling efficient study execution, reliable data generation, and consistent laboratory support throughout the research lifecycle.
As a central lab supporting various clinical trials and studies, Dr. Dangs Lab (DDL) is committed to maintaining high standards of quality, compliance, and laboratory governance across all our operations.
DDL is accredited by the NABL and has operated in alignment with ISO 15189 standards since 2001, including the current ISO 15189:2022 framework. Our laboratory was among the early adopters of this accreditation in India, reflecting a long-standing emphasis on quality-driven laboratory practices.
In our role as a central lab, Dr. Dangs Lab is GCLP-certified and adheres to applicable international guidelines and established quality practices, supporting analytical accuracy, data reliability, and regulatory-aligned laboratory performance in clinical research.
